Apply to trial NCT06285890

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 1Drug trial

Phase I Study of HC-7366 for Acute Myeloid Leukemia

To find a recommended dose of HC-7366 to patients with AML. The safety and effects of this drug combination will also be studied.

How this works

  1. Answer a few questions

    About 5 to 10 minutes. Skip-friendly where possible.

  2. We forward your profile to the study team

    They see only the answers needed to decide if you can be screened.

  3. The team reaches out to schedule screening

    Usually within a few business days, via the contact you give.

We save your progress under this email so you can come back later, and the study team uses it to reach you.

By clicking Start, you agree to our terms of service.